Targeting cancer from many angles
Killian Award recipient Tyler Jacks fosters interdisciplinary, innovative cancer research.
Tracing a cellular family tree
New technique allows tracking of gene expression over generations of cells as they specialize.
Scientists discover how cancer cells escape blood vessels
Study offers new targets for drugs that may prevent cancer from spreading.
A new way to deliver microRNAs for cancer treatment
Scientists exploit gene therapy to shrink tumors in mice with an aggressive form of breast cancer.
M+Visión Fellow Carlos Castro named one of Spain’s top young innovators
Postdoc researcher recognized for leukemia management innovation.
Tackling cancer research from multiple perspectives
Graduate student Tushar Kamath takes an interdisciplinary approach to cancer research.
$20 million Commonwealth Foundation for Cancer Research gift to expand collaborative cancer research
Gift will augment the Bridge Project, a collaborative project between the Dana-Farber/Harvard Cancer Center and MIT's Koch Institute.
Biologists unravel drug-resistance mechanism in tumor cells
Targeting the RNA-binding protein that promotes resistance could lead to better cancer therapies.
Capturing cell growth in 3-D
Spinout’s microfluidics device better models how cancer and other cells interact in the body.
How chronic inflammation can lead to cancer
Researchers discover how the immune system can create cancerous DNA mutations when fighting off infection.
Real-time data for cancer therapy
Biochemical sensor implanted at initial biopsy could allow doctors to better monitor and adjust cancer treatments.
Identifying a key growth factor in cell proliferation
Researchers discover that aspartate is a limiter of cell proliferation.
Study: Firms “underinvest” in long-term cancer research
Tweaks to the R&D pipeline could create new drugs and greater social benefit.
Seeking rare cells
Christopher Love uses microscale technology to isolate rare cells, yielding insight into human disease.